Xiaofen He Selected Research

Hyperalgesia

2/2024	Electroacupuncture Alleviates Hyperalgesia and Anxiety-Like Behaviors in Pain Memory Model Rats Through Activation of GABAergic Neurons and GABA Receptor in the Rostral Anterior Cingulate Cortex.
2/2024	Electroacupuncture alleviates streptozotocin-induced diabetic neuropathic pain via suppressing phosphorylated CaMKIIα in rats.
12/2023	Electroacupuncture alleviates mechanical allodynia and anxiety-like behaviors induced by chronic neuropathic pain via regulating rostral anterior cingulate cortex-dorsal raphe nucleus neural circuit.
7/2023	Electroacupuncture improves gout arthritis pain via attenuating ROS-mediated NLRP3 inflammasome overactivation.
1/2023	Satellite glial cells drive the transition from acute to chronic pain in a rat model of hyperalgesic priming.
1/2021	Rostral Anterior Cingulate Cortex-Ventrolateral Periaqueductal Gray Circuit Underlies Electroacupuncture to Alleviate Hyperalgesia but Not Anxiety-Like Behaviors in Mice With Spared Nerve Injury.
12/2020	Electroacupuncture alleviates diabetic neuropathic pain in rats by suppressing P2X3 receptor expression in dorsal root ganglia.
1/2020	Electroacupuncture Alleviates Mechanical Allodynia of a Rat Model of CRPS-I and Modulates Gene Expression Profiles in Dorsal Root Ganglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaofen He Research Topics

Disease

21	Pain (Aches) 03/2024 - 01/2017
11	Chronic Pain 11/2023 - 09/2015
8	Hyperalgesia 02/2024 - 01/2020
5	Neuralgia (Stump Neuralgia) 02/2024 - 12/2020
2	Inflammation (Inflammations) 03/2024 - 09/2015
2	Wounds and Injuries (Trauma) 10/2023 - 01/2023
2	Arthritis (Polyarthritis) 07/2023 - 04/2018
2	Neuroinflammatory Diseases 01/2023 - 02/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 02/2021
2	Postherpetic Neuralgia 01/2022 - 11/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2021 - 07/2020
2	Body Weight (Weight, Body) 12/2020 - 09/2019
2	Experimental Arthritis 04/2018 - 09/2015
1	Allergic Contact Dermatitis 03/2024
1	Gout 07/2023
1	Shoulder Pain 01/2023
1	Ankle Injuries (Ankle Injury) 01/2023
1	Neoplasms (Cancer) 02/2021
1	Tenosynovitis 10/2020
1	Stable Angina 04/2020
1	Anxiety Disorders (Anxiety Disorder) 01/2020
1	Hypercholesterolemia 09/2019
1	Pathologic Constriction (Stenosis) 04/2011

Drug/Important Bio-Agent (IBA)

5	CarrageenanIBA 02/2024 - 01/2021
4	Freund's AdjuvantIBA 12/2023 - 01/2017
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 09/2015
3	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2023
3	Therapeutic UsesIBA 11/2023 - 10/2020
2	GABA Receptors (GABA Receptor)IBA 02/2024 - 11/2023
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2019
2	Anti-Anxiety Agents (Anxiolytics)IBA 11/2023 - 11/2023
2	LipidsIBA 10/2023 - 01/2023
2	Dinoprostone (PGE2)FDA Link 01/2023 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 11/2021 - 01/2021
2	Collagen Type II (Type II Collagen)IBA 04/2018 - 09/2015
1	CytokinesIBA 03/2024
1	Interleukin-33IBA 03/2024
1	KN 93IBA 02/2024
1	Streptozocin (Streptozotocin)FDA Link 02/2024
1	Glutamic Acid (Glutamate)FDA Link 12/2023
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 11/2023
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 10/2023
1	InflammasomesIBA 07/2023
1	Colchicine FDA LinkGeneric 07/2023
1	Uric Acid (Urate)IBA 07/2023
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2023
1	Protein Kinase C-epsilonIBA 01/2023
1	Chemokine CXCL1IBA 01/2023
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2021
1	Nerve Growth Factors (Neurotrophins)IBA 02/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021
1	ParvalbuminsIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	A-317491IBA 12/2020
1	Purinergic P2X3 ReceptorsIBA 12/2020
1	Blood Glucose (Blood Sugar)IBA 12/2020
1	Purinergic Receptors (Receptors, Purine)IBA 12/2020
1	prostaglandin-inositol cyclic phosphateIBA 01/2020
1	CholesterolIBA 09/2019
1	Atorvastatin (Lipitor)FDA Link 09/2019
1	oxidized low density lipoproteinIBA 09/2019
1	EndorphinsIBA 04/2018
1	Opioid Analgesics (Opioids)IBA 09/2015
1	FA 70IBA 04/2011

Therapy/Procedure

19	Electroacupuncture 02/2024 - 09/2015
5	Therapeutics 01/2023 - 01/2017
3	Acupuncture Therapy 01/2023 - 10/2020
3	Meridians (Jing Luo) 02/2021 - 04/2020
2	Injections 10/2023 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2023 - 02/2021
1	Pain Management 07/2023
1	Analgesia 09/2022
1	Acupuncture Points (Acupuncture Point) 02/2021
1	Conservative Treatment 10/2020
1	Intradermal Injections 04/2018